Fideres’s research on generic drug pricing was covered today by Bloomberg. The research analysed price increases for individual generic drugs among different manufacturers and the timings of these price increases. The coverage of Fideres’s work comes as the Department of Justice continues their investigation into alleged collusion by drug manufacturers.
The full article can be found here.
Fideres’s Co-Founder, Steffen Hennig, contributes to The Group Litigation And Class Actions 2023 organized by Thoughtleaders4, 10-11 October in ...
Hagens Berman and Sperling & Slater filed a landmark multi-billion-dollar antitrust class action lawsuit against PayPal. Fideres provided the e...
Fideres has entered an agreement with Italian law firm Studio Legale Scoccini & Associati, Spanish law firm CCS Abogados, and litigation funder...
London: +44 20 3397 5160
New York: +1 646 992 8510
Rome: +39 06 8587 0405
Frankfurt: +49 61 7491 63000
Johannesburg: +27 11 568 9611